Mutares Acquired Czech Chemical Producer Synthomer a.s.
The firm added the acrylics manufacturer to its Chemicals & Materials portfolio to drive operational improvements.
Updated on Oct. 5, 2026 in Business Strategy
Live Poll
Do you believe corporate acquisitions aimed at operational restructuring typically benefit the economy?
Mutares has finalized its acquisition of Synthomer a.s., a Czech manufacturer specializing in acrylic acids and esters. The move integrates the company into the Mutares Chemicals & Materials segment as a platform for future optimization.
Why it matters
This transaction reflects the strategy of Mutares to acquire firms in special situations to pursue commercial and operational enhancements. For operators, it highlights how private equity structures platform investments to scale specialized manufacturing units.
Synthomer a.s. generated EUR 110 million in 2025 revenue with a workforce of 300 employees. The deal incorporates these assets into the existing Chemicals & Materials segment managed by Mutares.
The players
Mutares
A German private equity firm that acquires businesses in special situations to conduct operational and commercial restructuring.
Synthomer a.s.
A Czech-based chemical company specializing in the production of acrylic acids and acrylic esters.
The details
Mutares focuses on acquiring underperforming or special-situation businesses to implement rigorous operational overhauls. By adding Synthomer a.s. to its portfolio, the firm intends to apply its proprietary optimization strategy to improve the profitability of the acrylic acid and ester production lines. This strategy typically involves streamlining supply chain logistics and production efficiency to increase margin profiles within the chemical sector.
Timeline
Synthomer a.s. generated EUR 110 million in revenue during 2025.
Mutares completed the acquisition in October 2026.
Market Landscape
This acquisition follows the established pattern of Mutares utilizing its Chemicals & Materials segment to anchor and optimize regional industrial assets. It reinforces a trend among holding firms to leverage specific industrial niches as platforms for centralized commercial management.
Operators in the chemical manufacturing space should monitor how Mutares integrates these production lines, as changes to procurement and supply chain terms are likely. Benchmarking your operational costs against this newly integrated entity can help identify regional competitive shifts.
The takeaway
The acquisition underscores the potential for operational optimization within the specialized chemical production sector. Managers should track the performance metrics of the Chemicals & Materials segment in future quarterly reports to gauge the efficacy of this restructuring model.
Further reading
For more on how holding firms restructure portfolio assets, see our Business Strategy archive.
Source note: This article includes information reported by Alchempro.
Live Poll
Do you believe corporate acquisitions aimed at operational restructuring typically benefit the economy?
